Clinical Trials Logo

Pharmacist-Patient Relations clinical trials

View clinical trials related to Pharmacist-Patient Relations.

Filter by:

NCT ID: NCT06029842 Completed - Clinical trials for Pharmacist-Patient Relations

The Role of a Clinical Pharmacist in the Management of Type 2 Diabetic Patients in a Primary Medical Center in Jordan

Start date: October 17, 2022
Phase: N/A
Study type: Interventional

This study aimed to assess the impact of the clinical pharmacist on enhancing type 2 diabetic patients outcomes in a primary health care center.

NCT ID: NCT05970471 Not yet recruiting - Cancer Clinical Trials

Preferences of Patients Treated With Oral Cancer Drugs and Informal Caregivers for Pharmaceutical Consultation in Hospital

IMPLICATION
Start date: September 1, 2023
Phase:
Study type: Observational

To ensure the safe use of oral anticancer drugs, oncology pharmacy consultations (OPCs) have been established in France. Their goal is to provide the patient with the means to identify, prevent and limit adverse effects and to know who to refer to in case of a serious adverse effect, perform a pharmaceutical analysis of the prescription, and participate in the improvement and evaluation of overall compliance. OPCs are conditioned by the needs, expectations, and involvement of the patients in their care. In healthcare, patients are increasingly encouraged to play an active role in the knowledge and management of their health, express their concerns and preferences, and participate in medical decisions. Thus, it is essential to elicit their preferences. The discrete-choice experiment (DCE) is the validated and recommended method of the International Society for Pharmacoeconomics and Outcomes Research for such a task.

NCT ID: NCT05751772 Terminated - Clinical trials for Medication Adherence

Improving Knowledge in Heart Failure Inpatient With Therapeutic Education

EDUC-IC
Start date: December 13, 2022
Phase: N/A
Study type: Interventional

The objective is to evaluate the impact of a pharmacist-led therapeutic education intervention on the knowledge of hospitalized heart failure patients. The knowledge score on heart failure disease and medications will be compared between two groups one month after hospitalization. The intervention group will receive a therapeutic education intervention and usual hospital care and the control group will receive only usual hospital care.

NCT ID: NCT05580757 Completed - Suicide Clinical Trials

Pharmacists as Gate Keepers in Suicide Prevention: Needs of Pharmacists

Start date: September 2, 2022
Phase:
Study type: Observational

This study aims to examine the opinions and needs of pharmacists and pharmaceutical technical assistants (FTA) concerning their role as gatekeepers in suicide prevention. The primary objective is to map the experiences and needs of (public) pharmacists and FTA with regard to suicide prevention. The secondary objective is to be able to develop more targeted tools, interventions or trainings based on the results of the needs assessment in order to facilitate the role of (public) pharmacists and FTA as gatekeepers in suicide prevention.

NCT ID: NCT05488002 Not yet recruiting - Obesity Clinical Trials

Pharmacists Interventions on Patients Diabetic, and Obese Patients in the UAE: Randomized Controlled Trials.

Start date: August 1, 2022
Phase: N/A
Study type: Interventional

Hypertension, diabetes, and obesity are considered major risk factors for cardiovascular diseases and premature mortality worldwide. Furthermore, they have severe consequences on quality of life among patients. With increasing challenges facing the healthcare systems, pharmacists are well positioned to take on a greater role in the management of chronic diseases. The present study aims to investigate the impact of pharmacist counselling on the clinical outcomes (weight, mortality, blood pressure, blood glucose) of hypertensive, diabetic, and obese patients.

NCT ID: NCT05461066 Completed - Smoking Cessation Clinical Trials

Cost-effectiveness of a Tobacco Cessation Care Service in the Community Pharmacy

CESAR
Start date: January 1, 2016
Phase: N/A
Study type: Interventional

The study was a non-randomized controlled trial of 12-months' follow-up with 182 Spanish community pharmacists. Intervention community pharmacists received the CESAR training to improve their smoking cessation services, consisting of an initial interview and follow-up visits to identify obstacles and reinforce behaviours. The control group received the usual care. Data were self-reported and collected in a computerized health registration system. Outcomes were smoking cessation and quality of life (EuroQOL-5D) collected at baseline, 6 months', and 12 months' follow-up. Cost data were collected for the study period and included direct health costs, sick leave, and intervention costs. Smoking cessation was analysed through logistic regression models. Generalized linear models were carried out for quality-adjusted life year costs. Incremental cost-effectiveness ratios (ICERs) and cost-utility ratios (RCUI) were calculated. Sensitivity analyses were performed.

NCT ID: NCT05416892 Completed - Clinical trials for Pharmacist-Patient Relations

What is the Impact of Implementing Pharmaceutical Algorithms in the PharmaClass® Software, on the Handling the Patient's Medication Load, by the Clinical Pharmacist?

Start date: September 14, 2021
Phase:
Study type: Observational

The clinical pharmacists present in the hospitalisation units aim to ensure the daily review of the drug prescriptions of hospitalized patients. In order to optimize their work, the objective of this study would be to provide them with a clinical decision support tool via artificial intelligence in order to improve the patient's medication management. This study will test the Pharmaclass® software.

NCT ID: NCT05252221 Completed - Clinical trials for Alcohol Use Disorder (AUD)

Alcohol Telemedicine Consultation in Primary Care (ATC)

ATC
Start date: September 14, 2021
Phase: N/A
Study type: Interventional

This pragmatic, cluster-randomized trial in adult primary care clinics in a healthcare system with a diverse membership will examine the effectiveness of an innovative, multi-faceted intervention, the Addiction Telemedicine Consultant (ATC) service using clinical pharmacists to facilitate alcohol use problems and alcohol use disorder (AUD) pharmacotherapy and specialty addiction treatment entry.

NCT ID: NCT05141266 Recruiting - Clinical trials for Opioid-Related Disorders

Healthy Opioid Prescription Engagement

HOPE
Start date: November 8, 2021
Phase: N/A
Study type: Interventional

This study is a randomized controlled trial across 14 community pharmacies to test the efficacy of the Brief Intervention-Medication Therapy Management intervention (BI-MTM). The establishment of the BI-MTM model will result in a major impact for addressing the opioid epidemic, preventing opioid use disorder and overdose, and safeguarding patient health in a novel community-based service setting.

NCT ID: NCT04410575 Recruiting - Clinical trials for Major Depressive Disorder

Mental Health Assessment and Prescribing by Alberta Pharmacists

MAP-AP
Start date: March 22, 2023
Phase: N/A
Study type: Interventional

This is a clinical trial evaluating the experimental intervention of enhanced pharmacist care by pharmacists with additional prescribing authorization (APA) in Alberta, for patients newly diagnosed with Major Depressive Disorder (MDD) and Generalized Anxiety Disorder (GAD).